Paul Josephs, Chief Executive Officer at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), bought 17,000 shares at $5.74 ($98K) on 2025-01-08, disclosed to the SEC on 2025-01-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.